Pune divisional commissioner Saurabh Rao and district collector Rajesh Deshmukh visited the plant on Wednesday.
Share Via Email
| A+A A- By PTI
PUNE: Biovet Pvt Ltd, an associate firm of Bharat Biotech, is confident of making a plant at Manjari in Pune fully functional for vaccine production by August- end, a senior administrative official has said.
Hyderabad-based Bharat Biotech is the manufacturer of Covaxin, one of the two vaccines being used in the nationwide COVID-19 inoculation drive.
Pune divisional commissioner Saurabh Rao and district collector Rajesh Deshmukh visited the plant on Wednesday.
The Bombay High Court recently permitted Biovet to take possession of a ready-to-use vaccine manufacturing plant, built on a 12-hectare plot at Manjari in Pune, to produce Covaxin.
India should collaborate with other countries to ramp up COVID vaccine capability, says Fauci By Reena Bhardwaj | Updated: May 14, 2021 07:34 IST
Washington [US], May 14 (ANI): Dr Anthony Fauci, the Biden administration s top medical adviser on Thursday (local time) said that it is imperative for India to collaborate with other countries, and companies to ramp up its vaccine production capability to vaccinate country s huge population against COVID-19.
Calling India as one of the best vaccine producer in the world, the leading American infectious disease expert said, It s a very very large country with a population of about 1.4 billion people, you only have a couple of percentage of the people who are fully vaccinated and over about 10 per cent or so that have at least one dose so you ve got to work out arrangements with other countries, other companies at the same time as ramping up your own capability of making vaccines because as we all kn
Amid a political war of words between the Centre and the Delhi government over the availability of sufficient vaccines to inoculate all adults in the national capital, the central government on Thursday said it will provide all possible assistance to all companies willing to manufacture the vaccine to ramp up the supply. It, however, flagged the non-availability of a sophisticated laboratory with most vaccine makers that is necessary to produce the indigenously developed Covaxin jab. The Centre also rejected Delhi government s claim that Covaxin maker Bharat Biotech has refused to provide additional vaccine doses to the Delhi government, saying the national capital has received over 15 lakh doses of the vaccine and its role is to facilitate the states.
1493
New Delhi, May 14
Amid a political war of words between the Centre and the Delhi government over the availability of sufficient vaccines to inoculate all adults in the national capital, the central government on Thursday said it will provide all possible assistance to all companies willing to manufacture the vaccine to ramp up the supply.
It, however, flagged the non-availability of a sophisticated laboratory with most vaccine makers that is necessary to produce the indigenously developed Covaxin jab.
The Centre also rejected Delhi government s claim that Covaxin maker Bharat Biotech has refused to provide additional vaccine doses to the Delhi government, saying the national capital has received over 15 lakh doses of the vaccine and its role is to facilitate the states.
Highlights
Bharat Biotech is ready to share Covaxin formula with other manufacturers, says Centre
The govt also rejected the Delhi government s claim that Covaxin maker Bharat Biotech has refused to provide additional vaccine doses to the Delhi government,
New Delhi: Amid a political war of words between the Centre and the Delhi government over the availability of sufficient vaccines to inoculate all adults in the national capital, the central government has said that leading drug maker Bharat Biotech is ready to share the formula of its anti-COVID vaccine
COVAXIN with other manufacturers.
Bharat Biotech has welcomed this on Thursday, according to ANI